Market Leadership Lumea is the leading provider in primary digital pathology in the U.S., processing the highest volume of primary digital diagnoses nationwide, which indicates a strong market position and potential for expanding its customer base within pathology laboratories and healthcare institutions.

Strategic Partnerships Recent collaborations with Voicebrook, ZayaAI, and Mopec Group demonstrate Lumea’s active engagement in forming strategic alliances, creating opportunities to offer integrated solutions and access new customer segments across pathology, radiology, and related fields.

Recognition & Awards Lumea has received multiple industry awards and recognition, including the Utah Best of State and inclusion on the Inc. 5000 list, which can be leveraged to build credibility with prospective clients seeking innovative and award-winning technology.

Growth Potential With a revenue range between $25M and $50M and a rapidly expanding global presence spanning five continents, there are significant sales opportunities to target international markets and larger healthcare organizations seeking digital pathology solutions.

Healthcare Focus Lumea’s emphasis on improving cancer diagnostics and tissue handling efficiency presents opportunities to engage hospitals, diagnostics labs, and specialty clinics aiming to enhance diagnostic accuracy and operational ROI through advanced AI-driven workflows.